Header Logo

Connection

Angela Woodiwiss to Cardiotonic Agents

This is a "connection" page, showing publications Angela Woodiwiss has written about Cardiotonic Agents.
Connection Strength

0,526
  1. Impact and mechanisms of action of neurotensin on cardiac contractility in the rat left ventricle. Eur J Pharmacol. 2005 Sep 27; 520(1-3):108-17.
    View in: PubMed
    Score: 0,255
  2. The G-308A polymorphism of the TNF-alpha gene does not predict changes in cardiac function in response to medical therapy for idiopathic dilated cardiomyopathy. Cardiovasc J Afr. 2008 Sep-Oct; 19(5):254-8.
    View in: PubMed
    Score: 0,078
  3. Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy. Pharmacogenomics J. 2007 Oct; 7(5):339-45.
    View in: PubMed
    Score: 0,069
  4. Inotropic responses to phosphodiesterase inhibitors in cardiac hypertrophy in rats. Eur J Pharmacol. 2005 May 09; 514(2-3):201-8.
    View in: PubMed
    Score: 0,062
  5. Attenuated beta-adrenoceptor-mediated cardiac contractile responses following androgenic steroid administration to sedentary rats. Eur J Appl Physiol. 2000 Mar; 81(4):310-6.
    View in: PubMed
    Score: 0,043
  6. Susceptibility to systolic dysfunction in the myocardium from chronically infarcted spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2008 Jan; 294(1):H372-8.
    View in: PubMed
    Score: 0,018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.